Goodwin + KPMG 7th Annual Symposium @ JP Morgan Healthcare Conference 2026

Goodwin and KPMG hosted our 7th Annual Symposium on January 14, 2026, during the 44th Annual J.P. Morgan Healthcare Conference week.

In today’s market, M&A and strategic transactions are increasingly critical to sustaining innovation and fueling growth for life sciences and healthcare companies. This year’s symposium spotlighted how industry leaders leverage dealmaking — not just as a response to capital constraints, but as a catalyst to advance pipelines, strengthen balance sheets, and position for long-term success.

See you at the next one!

Featured Insights

Continue the conversation with our select insights.

Life Sciences Capital Markets: Preparing for Your 2026 IPO

With an upswing in IPO activity, take advantage of these considerations when planning your capital markets strategy for your upcoming IPO.

The New Playbook for Competitive Life Sciences M&A — How Buyers Can Differentiate Beyond Price Through Structure and Strategy

As competition in life sciences M&A grows, the playbook on how to win deals is being rewritten. Discover emerging tactics and considerations to position yourself as the best buyer.

To Monetize or Not to Monetize? The Question Late-Stage Life Sciences Companies Should Be Asking

Royalty monetization deals have become important financing alternatives. What should life science companies be asking when it comes to fundraising?

2026 Agenda

Martina Boyce, Managing Director, Client Development, Life Sciences & Healthcare, Goodwin (MC)
Rachael Bushey, Life Sciences Partner, Co-Chair, Philadelphia Office, Goodwin
Kristin Ciriello Pothier, Life Sciences Sector Leader, Global Deal Advisory & Strategy Leader, Healthcare & Life Sciences, KPMG

Geoffrey von Maltzahn, CEO, Lila Sciences
Stuart Cable, Partner, Vice-Chair & Global Head of M&A, Goodwin
Joe Theis, Partner, Goodwin

Chris Huh, Director, Mergers & Acquisitions, Healthcare IT, Lincoln International
Vishva Mehta, Principal, Blackstone
Rich Siegel, Managing Director, Capital Solutions, Harris Williams
Chris Wilson, Partner, Co-Chair of Healthcare, Goodwin (Co-Moderator)
Brett Bell, Partner, KPMG (Co-Moderator)

Jeremy Janson, Principal, Frazier Healthcare Partners
Mark Martin, Managing Director, Global Head of Pharma Services & Technology, Houlihan Lokey
Brandon Rice, CEO, Weave Bio
John Jones, Partner, Co-Leader Healthcare Private Equity, Chair Healthcare Regulatory and Compliance, Goodwin (Moderator)
Joe Zaccaria, Managing Director, Healthcare & Life Sciences (HCLS), KPMG

Troy Sarich, PhD, BioPharma Sr. Executive, Advisor, Board Member
Mary Rozenman, PhD, CBO | CFO, insitro
Arvind Sundar-Rajan, SVP, Chief Digital and Strategy Officer, Revvity
Kristin Ciriello Pothier, Life Sciences Sector Leader, Global Deal Advisory & Strategy Leader, Healthcare & Life Sciences, KPMG
Steve Sapletal, Principal, US Strategy Leader, Life Sciences, KPMG

Dr. Chelsea Clinton, Vice Chair, Clinton Foundation
Seema Kumar, CEO, Cure
Deepa Rich, Partner, Goodwin (Moderator)

Clive Meanwell, MB, ChB, MD, Chair and Managing Partner, Population Health Partners
Rachael Bushey, Life Sciences Partner, Co-Chair, Philadelphia Office, Goodwin

Anthony Park Yu, Managing Director, Bank of America
Ivana Magovčević-Liebisch, PhD, JD, President and CEO, Draig Therapeutics
Danielle Lauzon, Partner, Co-Chair of Life Sciences M&A, Boston Business Law Leader, Goodwin (Moderator)
Robert Masella, Partner, Co-Chair of Public M&A, Goodwin
Arman Oruc, Partner, Co-Chair of Antitrust + Competition, Goodwin

Josh Gertsman, Partner, Aditum Bio
Weiyong Sun, CBO, Hansoh
Kathy He, Fractional CEO/CBO, Adviser to Founders and Boards, VIVREGEN LLC
David Chen, Partner, Goodwin
Wendy Pan, Partner, Chair of Goodwin Asia Life Sciences, Goodwin (Moderator)
Jeff Stoll, Partner, KPMG

Namandjé N. Bumpus, PhD, Founding Principal, Bumpus Advising (former Principal Deputy Commissioner of the FDA)
Susan Lee, Partner, Goodwin
Michael Buchanio, Managing Director - Deal Advisory & Strategy, KPMG

Alexander Schuth, MD, COO and CFO, Denali Therapeutics
Lyla Bibi, Partner, Goldman Sachs
Marshall Urist, MD, PhD, EVP and Head of Research & Investments, Royalty Pharma
Ben Marsh, Partner, Goodwin
Jackie Mercier, Partner, Co-Chair of the Structured Financing and Royalty Monetization, Goodwin
Vicki Love, Managing Director, KPMG (Moderator)

Get In Touch

For more information about our annual Symposium, please email us.

Previous Years

2025 Goodwin + KPMG 6th Annual Symposium @ JP Morgan

Browse the 2025 agenda and speaker list, and watch videos from the event.

2024 Goodwin + KPMG 5th Annual Symposium @ JP Morgan

Browse the 2024 agenda and speaker list, and watch videos from the event.

Learn More about Life Sciences and Healthcare at Goodwin

Life Sciences Practice

Our Life Sciences practice is uniquely positioned to partner with innovators and investors operating in a fast-moving, technology-driven environment. We work with life sciences companies throughout the corporate lifecycle, as well as with investors, banks, and others in the life sciences ecosystem.

Life Sciences Perspectives Blog

Our Life Sciences Perspectives blog is a resource specifically aimed at addressing your most frequent and pressing issues in this dynamic industry. We provide the insights you need most, including developments on private and public company matters, licensing deals and collaborations, patent and IP matters, FDA and healthcare regulatory compliance, and European and Asian developments for life sciences companies.